España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vera Therapeutics
VERA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$47.03
1.28
2.80%
At close: -
$47.03
0
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Vera Therapeutics (VERA) Forecast
News
Earnings
Vera Therapeutics (VERA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Vera Therapeutics (NASDAQ:VERA) Stock
Vera Therapeutics Stock (NASDAQ: VERA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 21, 2024
Wells Fargo Initiates Coverage On Vera Therap...
Benzinga Newsdesk
Friday, November 08, 2024
Wedbush Maintains Neutral on Vera Therapeutic...
Benzinga Newsdesk
Thursday, November 07, 2024
Vera Therapeutics Q3 EPS $(0.85) Misses $(0.6...
Benzinga Newsdesk
Tuesday, November 05, 2024
JP Morgan Maintains Overweight on Vera Therap...
Benzinga Newsdesk
Wednesday, October 30, 2024
Reported Earlier, Vera Therapeutics Prices $3...
Benzinga Newsdesk
Tuesday, October 29, 2024
Vera Therapeutics shares are trading lower af...
Benzinga Newsdesk
Monday, October 28, 2024
Vera Therapeutics Plans To Commence Public Of...
Benzinga Newsdesk
Guggenheim Maintains Buy on Vera Therapeutics...
Benzinga Newsdesk
Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years
Vandana Singh
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Vera Therapeutics shares are trading higher a...
Benzinga Newsdesk
Reported Saturday, Vera Therapeutics Reveals ...
Benzinga Newsdesk
Wednesday, October 16, 2024
Scotiabank Initiates Coverage On Vera Therape...
Benzinga Newsdesk
Thursday, October 03, 2024
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Wednesday, October 02, 2024
Vera Therapeutics To Present Long-term Result...
Benzinga Newsdesk
Vera Therapeutics Reports Expansion Of Its De...
Benzinga Newsdesk
Tuesday, October 01, 2024
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Monday, September 23, 2024
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Monday, September 16, 2024
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Vera Therapeutics shares are trading higher a...
Benzinga Newsdesk
Vera Therapeutics To Host In-Person R&D Day T...
Benzinga Newsdesk
Thursday, September 12, 2024
Vera Therapeutics Completes Enrollment For Pr...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Friday, September 06, 2024
Cantor Fitzgerald Reiterates Overweight on Ve...
Benzinga Newsdesk
Tuesday, September 03, 2024
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
JP Morgan Maintains Overweight on Vera Therap...
Benzinga Newsdesk
Tuesday, August 13, 2024
JP Morgan Maintains Overweight on Vera Therap...
Benzinga Newsdesk
Thursday, August 08, 2024
Vera Therapeutics Q2 EPS $(0.62) Misses $(0.5...
Benzinga Newsdesk
Monday, July 01, 2024
Vera Therapeutics Appoints David Johnson As C...
Benzinga Newsdesk
Monday, June 03, 2024
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Friday, May 31, 2024
Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady In April: This Week In The Market
Piero Cingari
JP Morgan Maintains Overweight on Vera Therap...
Benzinga Newsdesk
Wednesday, May 29, 2024
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
Piero Cingari
Tuesday, May 28, 2024
Vera Therapeutics shares are trading higher a...
Benzinga Newsdesk
Vera Therapeutics Receives FDA Breakthrough T...
Benzinga Newsdesk
Reported Saturday, Vera Therapeutics Presente...
Benzinga Newsdesk
Friday, May 10, 2024
Raymond James Maintains Strong Buy on Vera Th...
Benzinga Newsdesk
Thursday, May 09, 2024
UPDATE: Vera Therapeutics Q1 EPS $(0.56) Up ...
Benzinga Newsdesk
Thursday, April 11, 2024
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
Vandana Singh
Vera Therapeutics shares are trading higher i...
Benzinga Newsdesk
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Vera Therapeutics shares are trading higher i...
Benzinga Newsdesk
Watching Vera Therapeutics; Traders Circulati...
Benzinga Newsdesk
Friday, April 05, 2024
Guggenheim Reiterates Buy on Vera Therapeutic...
Benzinga Newsdesk
Wednesday, March 27, 2024
Vera Therapeutics shares are trading higher a...
Benzinga Newsdesk
Guggenheim Maintains Buy on Vera Therapeutics...
Benzinga Newsdesk
Thursday, March 21, 2024
Wedbush Maintains Neutral on Vera Therapeutic...
Benzinga Newsdesk
Wednesday, March 20, 2024
Vera Therapeutics: Q4 Earnings Insights
Benzinga Insights
Vera Therapeutics Reported FY23 EPS Loss of $...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch